|
Name |
Cladospolide B
|
Molecular Formula | C12H20O4 | |
IUPAC Name* |
(3Z,5S,6S,12S)-5,6-dihydroxy-12-methyl-1-oxacyclododec-3-en-2-one
|
|
SMILES |
C[C@H]1CCCCC[C@@H]([C@H](/C=C\C(=O)O1)O)O
|
|
InChI |
InChI=1S/C12H20O4/c1-9-5-3-2-4-6-10(13)11(14)7-8-12(15)16-9/h7-11,13-14H,2-6H2,1H3/b8-7-/t9-,10-,11-/m0/s1
|
|
InChIKey |
PLHJPQNLCWFPFY-VQPFVQDKSA-N
|
|
Synonyms |
Cladospolide B; 3347TRN2RH; 96443-55-9; (3Z,5S,6S,12S)-5,6-dihydroxy-12-methyl-1-oxacyclododec-3-en-2-one; (?)-Cladospolide C; UNII-3347TRN2RH; CLADOSPOLIDE B, (+)-; Q27896645; (4S,5S,11S)-4,5,11-Trihydroxy-2-dodecenoic acid 1,11-lactone; (3Z,5S,6S,12S)-5,6-DIHYDROXY-12-METHYLOXACYCLODODEC-3-EN-2-ONE; Oxacyclododec-3-en-2-one, 5,6-dihydroxy-12-methyl-, (3Z,5R,6R,12S)-; OXACYCLODODEC-3-EN-2-ONE, 5,6-DIHYDROXY-12-METHYL-, (3Z,5S,6S,12S)-
|
|
CAS | 96443-55-9 | |
PubChem CID | 11958189 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 228.28 | ALogp: | 1.4 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 16 | QED Weighted: | 0.618 |
Caco-2 Permeability: | -4.579 | MDCK Permeability: | 0.00004760 |
Pgp-inhibitor: | 0.963 | Pgp-substrate: | 0.034 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.062 |
Blood-Brain-Barrier Penetration (BBB): | 0.968 | Plasma Protein Binding (PPB): | 53.03% |
Volume Distribution (VD): | 0.336 | Fu: | 60.24% |
CYP1A2-inhibitor: | 0.019 | CYP1A2-substrate: | 0.386 |
CYP2C19-inhibitor: | 0.097 | CYP2C19-substrate: | 0.755 |
CYP2C9-inhibitor: | 0.043 | CYP2C9-substrate: | 0.24 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.133 |
CYP3A4-inhibitor: | 0.014 | CYP3A4-substrate: | 0.154 |
Clearance (CL): | 11.092 | Half-life (T1/2): | 0.775 |
hERG Blockers: | 0.026 | Human Hepatotoxicity (H-HT): | 0.264 |
Drug-inuced Liver Injury (DILI): | 0.304 | AMES Toxicity: | 0.959 |
Rat Oral Acute Toxicity: | 0.077 | Maximum Recommended Daily Dose: | 0.346 |
Skin Sensitization: | 0.925 | Carcinogencity: | 0.331 |
Eye Corrosion: | 0.331 | Eye Irritation: | 0.949 |
Respiratory Toxicity: | 0.655 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002098 | 1.000 | D07GRH | 0.323 | ||||
ENC003404 | 0.679 | D04URO | 0.273 | ||||
ENC004377 | 0.679 | D03DVJ | 0.250 | ||||
ENC004602 | 0.563 | D08MRN | 0.238 | ||||
ENC004599 | 0.563 | D0P6VV | 0.234 | ||||
ENC003186 | 0.521 | D0N4PZ | 0.230 | ||||
ENC006036 | 0.521 | D0Z1FX | 0.226 | ||||
ENC001414 | 0.516 | D0D1SG | 0.223 | ||||
ENC005098 | 0.515 | D07WFK | 0.221 | ||||
ENC002215 | 0.515 | D0L9ZR | 0.220 |